Author:
Yamamoto M.,Yokochi M.,Kuno S.,Hattori Y.,Tsukamoto Y.,Narabayashi H.,Tohgi H.,Mizuno Y.,Kowa H.,Yanagisawa N.,Kanazawa I.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference25 articles.
1. Barbeau A (1974) The clinical physiology of side effects in long-term L-dopa therapy. Adv Neurol 5: 347?365
2. Bartholini G, Kuruma I, Pletscher A (1971) 3-O-methyldopa, new precursor of dopamine. Nature 230: 533?534
3. Bartholini G, Kuruma I, Pletscher A (1972) The metabolic pathway of L-3-O-methyldopa. J Pharmacol Exp Ther 183: 68?73
4. Brannan T, Mart�nez-Tica J, Yahr MD (1992) Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats. Neurology 42: 683?685
5. Calne DB, Reid JL, Vakil SD (1974) Parkinsonism treated with 3-O-methyldopa. Clin Pharmacol Ther 38: 533?536
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献